Synlogic Stock Fundamentals
| SYBX Stock | USD 1.26 0.06 5.00% |
Synlogic fundamentals help investors to digest information that contributes to Synlogic's financial success or failures. It also enables traders to predict the movement of Synlogic Stock. The fundamental analysis module provides a way to measure Synlogic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Synlogic stock.
Synlogic |
Synlogic Company Return On Equity Analysis
Synlogic's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Synlogic Return On Equity | -1.32 |
Most of Synlogic's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Synlogic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Synlogic has a Return On Equity of -1.3158. This is 94.51% lower than that of the Biotechnology sector and 96.39% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Synlogic Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Synlogic's current stock value. Our valuation model uses many indicators to compare Synlogic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Synlogic competition to find correlations between indicators driving Synlogic's intrinsic value. More Info.Synlogic is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Synlogic's earnings, one of the primary drivers of an investment's value.Synlogic Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Synlogic's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Synlogic could also be used in its relative valuation, which is a method of valuing Synlogic by comparing valuation metrics of similar companies.Synlogic is currently under evaluation in return on equity category among its peers.
Synlogic Fundamentals
| Return On Equity | -1.32 | ||||
| Return On Asset | -0.36 | ||||
| Operating Margin | (9.01) % | ||||
| Current Valuation | (4.82 M) | ||||
| Shares Outstanding | 11.7 M | ||||
| Shares Owned By Insiders | 11.78 % | ||||
| Shares Owned By Institutions | 64.61 % | ||||
| Number Of Shares Shorted | 55.19 K | ||||
| Price To Book | 1.10 X | ||||
| Price To Sales | 5.05 X | ||||
| Revenue | 8 K | ||||
| Gross Profit | 2.78 M | ||||
| EBITDA | (23.01 M) | ||||
| Net Income | (23.36 M) | ||||
| Cash And Equivalents | 106.79 M | ||||
| Cash Per Share | 1.52 X | ||||
| Total Debt | 7.08 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 12.47 X | ||||
| Book Value Per Share | 1.12 X | ||||
| Cash Flow From Operations | (31.66 M) | ||||
| Short Ratio | 2.75 X | ||||
| Earnings Per Share | (1.92) X | ||||
| Target Price | 1.0 | ||||
| Beta | 0.73 | ||||
| Market Capitalization | 14.04 M | ||||
| Total Asset | 19.83 M | ||||
| Retained Earnings | (441.65 M) | ||||
| Working Capital | 12.7 M | ||||
| Net Asset | 19.83 M |
About Synlogic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Synlogic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Synlogic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Synlogic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease and Ginkgo Bioworks, Inc. Synlogic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 84 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Synlogic Stock Analysis
When running Synlogic's price analysis, check to measure Synlogic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synlogic is operating at the current time. Most of Synlogic's value examination focuses on studying past and present price action to predict the probability of Synlogic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synlogic's price. Additionally, you may evaluate how the addition of Synlogic to your portfolios can decrease your overall portfolio volatility.